Establishment Labs Holdings Inc. (ESTA)

Market Cap	1.97B +118.4%
Revenue (ttm)	211.08M +27.1%
Net Income	-51.06M
EPS	-1.72
Shares Out	29.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	494,185
Open	65.27
Previous Close	64.06
Day's Range	65.23 - 68.40
52-Week Range	28.67 - 83.31
Beta	1.08
Analysts	Strong Buy
Price Target	86.86 (+29.47%)
Earnings Date	May 6, 2026

About ESTA

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and i...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 19, 2018
• Employees: 1,004
• Stock Exchange: NASDAQ
• Ticker Symbol: ESTA
• Website: https://www.establishmentlabs.com

Financial Performance

In 2025, ESTA's revenue was $211.08 million, an increase of 27.14% compared to the previous year's $166.03 million. Losses were -$51.06 million, -39.64% less than in 2024.

Analyst Summary

According to 7 analysts, the average rating for ESTA stock is "Strong Buy." The 12-month stock price target is $86.86, which is an increase of 29.47% from the latest price.

Price Target

$86.86

(29.47% upside)

Analyst Consensus: Strong Buy